Successful neuropharmacological treatment of Myasthenia gravis: Report of eight cases

Research Communications in Biological Psychology and Psychiatry

Volumn 22, Issue 3-4, 1997, Pages 83-96

  Lechin, Fuad ^a,d   Van Der Dijs, Bertha ^a   Jara, Hector ^a   Baez, Scarlet ^a   Orozco, Beatriz ^a   Jahn, Eduardo ^a   Lechin, Marcel E ^b   Jimenez, Vladimir ^a   Lechin, Alex E ^c  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NONE   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUSPIRONE; CLONIDINE; HYDROCORTISONE; LEVOMEPROMAZINE; NORADRENALIN; PHENYLALANINE; PYRIDOSTIGMINE; SEROTONIN; TYROSINE; YOHIMBINE;

ADRENALIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; EXERCISE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MYASTHENIA GRAVIS; NEUROPHARMACOLOGY; NORADRENALIN BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; STANDING; THROMBOCYTE AGGREGATION;

EID: 0031544618     PISSN: 03622428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Bolay, H., Karabudak, R., Cemalettin, A., Candemir, H., Varh, K., Imir, T. and Kansu, E. (1998). Alpha interferon treatment in myasthenia gravis: Effects on natural killer cell activity. J. Neuroimmunol. 82: 109-115.
2. Boranic, M., Pericic, D., Poljak-Blazi, M., Sverko, V. and Marotti, T. (1990). Suppression of immune response in rats by stress and drugs interfering with metabolism of serotonin. In: Neuroimmune interactions. Ann. N.Y. Acad. Sci., Vol 496: 485-491.
3. Brennan, F.M. and Feldmann, M. (1996). Cytokines in autoimmunity. Curr. Opinion. Immunol. 8: 872-877.
4. Cohen-Kaminski, S., Duquenoyj, M. and Berrih-Aknin, S. (1993). Abnormal immuneregulation involving the IL-2/IL-2 receptor complex in myasthenia gravis. In: Perm, S., Richman, D.P., Ruff, R.L. and Lennon, V.A., eds. Myasthenia gravis and related disorders: Experimental and clinical aspects. Ann. N.Y. Acad. Sci., vol. 681: 283-284.
5. Cunnick, J.E., Lysle, D.T., Kucinski, B.J. and Rabin, B.S. (1990). Evidence that shock induced immune suppression is mediated by adrenal hormones and peripheral beta-adrenergic receptors. Pharmacol. Biochem. Behav. 36:.645-651.
6. 2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats. Psychopharmacology 77: 327-331.
7. Irwin, M. (1991). Cellular immune changes in stress and depression: Role of corticotropin releasing factor and endogenous peptides. In: Risch, S.C., ed. Central nervous system peptide mechanisms in stress and depression. Washington DC, Am. J. Psychiatric Press, 105-128.
8. Karalis, K., Muglia, L.J., Bae, D., Hilderbrand, E. and Majzoub, J.A. (1991). CRH and the immune system. J. Neuroimmunol. 72: 131-136.
9. Kouassi, E., Li, Y.S. and Revillard, J.P. (1990). Catecholamine regulation of mouse B cell activation: functional dichotomy between lps and anti-immunoglobulin antibody responses. In: O'Dorisio, M.S. and Panerai, A., eds. Messengers in a Neuroimmune Axis. Ann. N.Y. Acad. Sci., Vol 594: 391-392.
10. Kumar, R.K. and Penny, R. (1983). Cell-mediated immune deficiency in Hodgkin's disease. In: Inlglis JR, ed. T-lymphocytes today. Amsterdam, Elsevier Science Publisher, 183-185.
11. Lal, S., Thavundayil, J.X., Krishnan, B., Nair, N.P.V., Schwartz, G., Kiely, M.E. and Guyda, H. (1997). Effect of sleep deprivation on the growth hormone response to the alpha-2 adrenergic receptor agonist, clonidine, in normal subjects. J. Neural Transm. 104: 291-298.
12. Larsson, P.T., Hjemdahl, P., Olsson, G., Egberg, N. and Hornstra, G. (1989). Altered platelet function during mental stress and adrenalin infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. Clin. Sci. 76: 369-376.
13. Lechin, A.E., Varon, J., van der Dijs, B. and Lechin, F. (1994). Plasma catecholamines and indoleamines during attacks and remission on severe bronchial asthma: possible role of stress. Am. J. Respir. Crit. Care Med. 149: A778.
14. Lechin, F. (1992). Adrenergic-serotonergic influences on gallbladder motility and irritable bowel syndrome. Am. J. Physiol. (Gastrointest. Liver. Physiol.) 262: G375-G376.
15. Lechin, F. and van der Dijs, B. (1980). Physiological, clinical and therapeutical basis of a new hypothesis for headache. Headache 20: 77-84.
16. Lechin, F. and van der Dijs, B. (1981). Colon motility and psychological traits in the irritable bowel syndrome. Dig. Dis. Sci. 26: 474.
17. Lechin, F. and van der Dijs, B. (1984). Slow wave sleep (SWS), REM sleep (REMS), and depression. Res. Comm. Psychol. Psychiat. Behav. 9: 227-262.
18. Lechin, F., van der Dijs, B., Bentolila, A. and Pena, F. (1977a). Antidiarrheal effects of dihydroergotamine. J. Clin. Pharmacol. 17: 339-349.
19. Lechin, F., van der Dijs, B., Bentolila, A. and Peña, F. (1977b). The spastic colon syndrome. Therapeutic and pathophysiologic considerations. J. Clin. Pharmacol. 17: 431-440.
20. Lechin, F., van der Dijs, B., Bentolila, A. and Peña, F. (1978). The adrenergic influences on the gallbladder emptying. Am. J. Gastroenterol. 69: 662-668.
21. Lechin, F., van der Dijs, B., Insausti, C.L. and Gómez, F. (1982). Treatment of ulcerative colitis with thioproperazine. J. Clin. Gastroenterol. 4: 445-449.
22. Lechin, F., van der Dijs, B., Jackubowicz, D., Camero, R.E., Villa, S., Lechin, E. and Gomez, F. (1985a). Effects of clonidine on blood pressure, noradrenalin, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone subjects. Neuroendocrinology 40: 253-261.
23. Lechin, F., van der Dijs, B., Insausti, C.L., Gómez, F., Villa, S., Lechin, A.E. Arocha, L. and Oramas, O. (1985b). Treatment of ulcerative colitis with clonidine. J. Clin. Pharmacol. 25: 219-226.
24. Lechin, F., van der Dijs, B., Jackubowicz, D., Camero, R.E., Lechin, S., Villa, S., Reinfeld, B. and Lechin, M.E. (1987a). Role of stress in the exacerbation of chronic illness: effects of clonidine administration on blood pressure and plasma noradrenalin, cortisol, growth hormone and prolactin concentrations, Psychoneuroendocrinology 12: 117-129.
25. Lechin, F., van der Dijs, B., Azocar, J., Amat, J., Vitelli-Florez, G., Martinez, C., Lechin, S., Jimenez, V., Cabrera, A., Cardenas, M. and Villa, S. (1987b). Stress, immunology and cancer: Effect of psychoactive drugs. Arch. Ven. Farm. Clin.Ter. 6: 28-43.
26. Lechin, F., van der Dijs, B., Lechin, M., Camero, R., Lechin, A., Villa, S. and Reinfeld, B. (1989a). Intramuscular clonidine test in severely diseased patients. In: Lechin, F., van der Dijs, B., eds. Neurochemistry and clinical disorders: Circuitry of some psychiatric and psychosomatic syndromes. Boca Raton, Fla., CRC Press, 215-226.
27. Lechin, F., van der Dijs, B., Lechin, M.E., Amat, J., Lechin, A.E., Cabrera, A., Gómez, F., Acosta, E., Arocha, L., Villa, S. and Jimenez, V. (1989b). Pimozide therapy for trigeminal neuralgia. Arch. Neurol. 46: 960-963.
28. Lechin, F., van der Dijs, B., Rada, I., Jara, H., Lechin, A.E., Cabrera, A., Lechin, M.E., Jimenez, V., Gómez, F., Villa, S., Acosta, E. and Arocha, L. (1990a). Plasma neurotransmitters and cortisol in duodenal ulcer patients: role of stress. Dig. Dis. Sci. 35: 1313-1319.
29. Lechin, F., van der Dijs, B., Vitelli-Florez, G., Lechin-Báez, S., Azocar J., Cabrera, A., Lechin, A., Jara, H., Lechin, M., Gómez, F. and Arocha, L. (1990b). Psychoneuroendocrinologic and immunologic parameters in cancer patients: involvement of stress and depression. Psychoneuroendocrinology 15: 425-451.
30. Lechin, F., van der Dijs, B., Lechin, A.E., Lechin, M.E., Coll-Garcia, E., Jara, H., Cabrera, A., Jimenez, V., Gomez, F., Tovar, D., Rada, I. and Arocha, L. (1991). Doxepin therapy for postprandial symptomatic hypoglycemic patients: neurochemical, hormonal and metabolic disturbances. Clin. Sci. 80: 373-384.
31. Lechin, F., van der Dijs, B., Lechin, M.E., Baez, S., Jara, H., Lechin, A., Orozco, B., Rada, I., Cabrera, A., Jimenez, V. and Leon, G. (1992a). Effects of an oral glucose load on plasma neurotransmitters in humans: involvement of REM sleep? Neuropsychobiology 26: 4-11.
32. Lechin, F., van der Dijs, B., Lechin, M., Jara, H., Lechin, A., Cabrera, A., Rada, I., Orozco, B., Jimenez, V. and Valderrama, T. (1992b). Dramatic improvement with clonidine in acute pancreatitis with elevated catecholamine and cortisol plasma levels: Report of five cases. J. Med. 23: 339-351.
33. Lechin, F., van der Dijs, B., Lechin, M.E., Jara, H., Lechin, A., Baez, S., Orozco, B., Rada, I., Cabrera, A., Arocha, L., Jimenez, V. and Leon, G. (1993). Plasma neurotransmitters throughout oral glucose tolerance test in non-depressed essential hypertension patients. Clin. Exper. Hypertension 15: 209-240.
34. Lechin, F., van der Dijs, B., Lechin, A., Orozco, B., Lechin, M., Báez, S., Rada, I., León, G. and Acosta, E. (1994a). Plasma neurotransmitters and cortisol in chronic illness: Role of stress. J. Med. 25: 181-192.
35. Lechin, F., van der Dijs, B., Vitelli-Florez, G., Báez, S., Lechin, M.E., Lechin, A.E., Orozco, B., Rada, I., León, G. and Jimenez, V. (1994b). Peripheral blood immunological parameters in long-term benzodiazepine users. Clin. Neuropharmacol. 17: 63-72.
36. Lechin, F., van der Dijs, B., Orozco, B., Báez, S., Rada, I., Garcia, Z., Jara, H., Lechin, A.E. and Lechin, M.E. (1996a). Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise stress test in healthy humans before and after parasympathetic blockade with atropine. Res. Comm. Biol. Psychol. Psychiatry 21:.55-71.
37. Lechin, F., van der Dijs, B., Orozco, B., Lechin, A.E., Baez, S., Lechin, M.E., Benaim, M., Acosta, E., Arocha, L., Jimenez, V., Leon, G. and Garcia, Z. (1996b). Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in severely ill patients: a model of failing to cope with stress. Psychother. Psychosom. 65: 129-136.
38. Lechin, F., van der Dijs, B. and Lechin, M. (1996c). Plasma neurotransmitters and functional illness. (Review) Psychother. Psychosom. 65: 293-318.
39. Lechin, F., van der Dijs, B., Orozco, B., Lechin, M.E. and Lechin, A.E. (1996d). Increased levels of free-serotonin in plasma of symptomatic asthmatic patients. Arm. Allergy Asthma Immunol. 77: 245-253.
40. Lechin, F., van der Dijs, B. and Benaim, M. (1996e). Benzodiazepines: Tolerability in elderly patients.(Special article) Psychother. Psychosom. 65: 171-182.
41. Lechin, F., van der Dijs, B. and Benaim, M. (1996f). Stress vs depression. (Review). Prog. Neuro-Psychopharmacol. Biol. Psychiat. 20: 899-950.
42. Lechin, F., van der Dijs, B., Jara, H., Orozco, B., Báez, S., Benaim, M., Lechin, M.E. and Lechin, A.E. (1998a). Effects of buspirone on plasma neurotransmitters in healthy subjects. J. Neural Transm. 105: 561-573.
43. Lechin, F., van der Dijs, B., Orozco, B., Jara, H., Rada, I., Lechin, M.E. and Lechin, A.E. (1998b). Neuropharmacological treatment of bronchial asthma with an antidepressant drug: tianeptine. A double-blind crossover placebo-controlled study. Clin. Pharmacol. Ther. 64: 223-232.
44. Leonard, B.E. and Song, C. (1996). Stress and the immune system in the etiology of anxiety and depression. Pharmacol. Biochem. Behav. 54: 299-303.
45. Mantegazza, R., Antozzi, C., Peluchetti, D., Sghirlanzoni, A. and Cornelio, F. (1988). Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J. Neurol. 235: 449-453.
46. McEwen , F., Shirazian, D. and Grob, D. (1993). Production of interferon gamma and interleukin-2 by peripheral blood lymphocytes of patients with myasthenia gravis and other autoimmune diseases. In: Penn, S., Richman, D.P., Ruff, R.L. and Lennon, V.A., eds. Myasthenia gravis and related disorders: Experimental and clinical aspects. Ann. N.Y. Acad. Sci., vol 681: 315-318.
47. Morgan, E.L., Janda, J.A., McClurg, M.R. and Buchner, R.R. (1990). Neuroendocrine hormone-mediated suppression of human B cell. In: O'Dorisio, M.S. and Panerai, A., eds. Messengers in a Neuroimmune Axis. Ann. N.Y. Acad. Sci., Vol 594: 482-484.
48. Nicholson, B. and Kuchroo, V. (1996). Manipulation on the TH1/TH2 balance in autoimmune disease. Curr. Op. Immunol. 8: 837-842.
49. Osserman, K.E. and Genkins, G. (1966). Critical reappraisal of the use of edrophonium (tensilon) chloride test inmyasthenia gravis and significance of clinical classification. Ann. N.Y. Acad. Sci., vol. 135: 312-334.
50. Palermo, A., Bertalero, P., Pizza, N., Amelotti, R. and Libretti, A. (1987). Enhanced platelet serotonin release after adrenergic stress in arterial hypertension. J. Hypertens. 5: S141-S143.
51. Pallone, F., Fais, S.P., Annibale, B., Boirivant, M., Morace, S. and Delle-Fave, G. (1990). Modulatory Effects of somatostatin and vasoactive intestinal polipeptide in human intestinal lymphocytes. In: O'Dorisio, M.S. and Panerai, A., eds. Messengers in a neuroimmune axis. Ann. N.Y. Acad. Sci., Vol. 594: 408-410.
52. Ragheb, S., Ferrio, M.F. and Lisak, R.P. (1993). Response of peripheral blood mononuclear cells from myasthenia gravis patients to exogenous interleukin-2. In: Penn, S., Richman, D.P., Ruff, R.L. and Lennon, V.A., eds. Myasthenia gravis and related disorders: Experimental and clinical aspects. Ann. N.Y. Acad. Sci., vol. 681: 323-324.
53. Ragheb, S. and Lisak, R.P. (1993). Phenotypic and functional abnormalities of B cells in myasthenia gravis. In: Penn, S., Richman, D.P., Ruff, R.L. and Lennon, V.A., eds. Myasthenia gravis and related disorders: Experimental and clinical aspects. Ann. N.Y. Acad. Sci., vol. 681: 257-262.
54. Romagnani, S. (1996). TH1 and TH2 in human diseases. Clin. Immunol. Immunopathol. 80: 225-235.
55. Théze, J., Alzari, P.M. and Bertoglio, J. (1996). Interleukin 2 and its receptors: recent advances and new immunologic functions. Immunology Today 17: 481-482.
56. Walker, R.F. and Codd, E.E. (1985). Neuroimmunemodulatory interaction of norepinephrine and serotonin. J. Neuroimmunol. 10: 41-58.
57. Warren, R.P., Kane, K.K., Burger, R.A. and Singh, V.K. (1990). Serotonin induced suppression of lymphocyte dna synthesis and natural killer cell activity. In: O'Dorisio, M.S. and Panerai, A., eds, Neuropeptides and immunopeptides: Messengers in a neuroimmune axis. Ann. N.Y. Acad. Sci., vol. 594: 429-431.